As of Jun 21, 2024, Abbvie's P/E ratio was 14.02, a -71.43% change from the 49.08 P/E ratio recorded in the previous year.

The Abbvie P/E history

Abbvie Aktienanalyse

What does Abbvie do?

Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines. Abbvie ist eines der beliebtesten Unternehmen auf

P/E Details

Deciphering Abbvie's P/E Ratio

The Price to Earnings (P/E) Ratio of Abbvie is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Abbvie's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Abbvie is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Abbvie’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Abbvie Stock

What is the price-to-earnings ratio of Abbvie?

The price-earnings ratio of Abbvie is currently 14.02.

How has the price-earnings ratio of Abbvie changed compared to last year?

The price-to-earnings ratio of Abbvie has increased by -71.43% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Abbvie high compared to other companies?

Yes, the price-to-earnings ratio of Abbvie is high compared to other companies.

How does an increase in the price-earnings ratio of Abbvie affect the company?

An increase in the price-earnings ratio of Abbvie would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Abbvie affect the company?

A decrease in the price-earnings ratio of Abbvie would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Abbvie?

Some factors that influence the price-earnings ratio of Abbvie are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Abbvie pay?

Over the past 12 months, Abbvie paid a dividend of 5.92 USD . This corresponds to a dividend yield of about 3.44 %. For the coming 12 months, Abbvie is expected to pay a dividend of 6.04 USD.

What is the dividend yield of Abbvie?

The current dividend yield of Abbvie is 3.44 %.

When does Abbvie pay dividends?

Abbvie pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Abbvie?

Abbvie paid dividends every year for the past 101 years.

What is the dividend of Abbvie?

For the upcoming 12 months, dividends amounting to 6.04 USD are expected. This corresponds to a dividend yield of 3.51 %.

In which sector is Abbvie located?

Abbvie is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abbvie kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abbvie from 5/15/2024 amounting to 1.55 USD, you needed to have the stock in your portfolio before the ex-date on 4/12/2024.

When did Abbvie pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Abbvie in the year 2023?

In the year 2023, Abbvie distributed 5.64 USD as dividends.

In which currency does Abbvie pay out the dividend?

The dividends of Abbvie are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Abbvie stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Abbvie

Our stock analysis for Abbvie Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbvie Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.